Hypersensitivity News and Research

RSS

Hypersensitivity is an exaggerated response by the immune system to a drug or other substance.

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Decoding abnormal touch sensitivity in autism spectrum disorders

The inability to tolerate light touch is a telltale feature of autism and one of the disorder's many perplexing symptoms. It has defied treatment, and its precise origins have remained somewhat of a mystery.

12 Aug 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

FDA grants approval for generic versions of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.

22 Jul 2019

Marijuana isn’t a great choice for glaucoma treatment, says expert

Marijuana can help reduce the pressure inside the eye (IOP, or intraocular pressure). Being a euphoric drug, it is now a commonly used recreational and medicinal drug. In fact, its use ranks fourth among all substances, behind tobacco, alcohol and caffeine.

18 Jul 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Proteasome inhibitors show potential for combating multidrug-resistant malaria

Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.

From PLOS ONE 10 Jun 2019

New statement highlights occupational burden of non-cancerous lung diseases

More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS’s American Journal of Respiratory and Critical Care Medicine.

3 Jun 2019

UAB study reveals detrimental role of neutrophils in multiple sclerosis

Multiple sclerosis is an autoimmune disease that damages the insulating sheaths of nerve cells of the central nervous system. People with the disease can lose vision, suffer weak limbs, show degenerative symptoms and exhibit impaired cognition.

26 May 2019

Combination of different treatments can have a positive effect for IBS sufferers

The more abnormalities in intestinal and brain function that IBS sufferers have, the more severe their symptoms of this functional bowel disorder, and the more adversely their everyday life is affected.

15 May 2019

FDA approves new treatment for children with lupus

The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.

27 Apr 2019

Researchers find potential new target for chronic pain treatment

A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.

7 Mar 2019

ACROBiosystems opens new Innovation laboratory in Delaware

January 18, 2018, ACROBiosystems officially opened its New Innovation laboratory in the Delaware Innovation Space in Wilmington, Delaware, USA, and held a grand opening ceremony.

From ACROBiosystems 7 Mar 2019

Abnormal timing found in the brains of people with autistic symptoms

The neural 'time windows' in certain small brain areas contribute to the complex cognitive symptoms of autism, new research suggests.

13 Feb 2019

Study may lead to a greater understanding of the mechanisms behind neuropathic pain

In animal models of a totally crushed peripheral nerve, the damaged axons are broken down, allowing healthy ones to regrow.

1 Feb 2019

Researchers compare treatment options for fecal incontinence

It is a common health problem that causes uncommon personal discomfort. Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence.

29 Jan 2019